Molecular characterization of streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1402-1407

  Zulz, Tammy ^a   Wenger, Jay D ^a   Rudolph, Karen ^a   Robinson, D Ashley ^b   Rakov, Alexey V ^b   Bruden, Dana ^a   Singleton, Rosalyn J ^a   Bruce, Michael G ^a   Hennessy, Thomas W ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; DISEASE CARRIER; EPIDEMIC; GENETIC ANALYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RURAL POPULATION; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; CLASSIFICATION; GENETICS; MICROBIAL SENSITIVITY TEST; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; SEROTYPING;

STREPTOCOCCUS PNEUMONIAE;

ALASKA; BACTERIAL TYPING TECHNIQUES; DISEASE OUTBREAKS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; RURAL POPULATION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84876763659     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02880-12     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. 2011. Recommended immunization schedules for persons aged 0 through 18 years-United States, 2011. MMWR Morb. Mortal. Wkly. Rep. 60(5):1-4.
2. Centers for Disease Control and Prevention. 2011. Recommended adult immunization schedule-United States, 2011. MMWR Morb. Mortal. Wkly. Rep. 60(4):1-4.
3. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.
4. Said MA, O'Brien KL, Nuorti JP, Singleton R, Whitney CG, Hennessy TW. 2011. The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine 29:5355-5362.
5. Gessner BD, Ussery XT, Parkinson AJ, Breiman RF. 1995. Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age. Pediatr. Infect. Dis. J. 14: 123-128.
6. Wenger JD, Zulz T, Bruden D, Singleton R, Bruce MG, Bulkow L, Parks D, Rudolph K, Hurlburt D, Ritter T, Klejka J, Hennessy T. 2010. Invasive pneumococcal disease in Alaskan children: impact of the sevenvalent pneumococcal conjugate vaccine and the role of water supply. Pediatr. Infect. Dis. J. 29:251-256.
7. Hausdorff WP, Feikin DF, Klugman KP. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93.
8. Gratten M, Morey F, Dixon J, Manning K, Torzillo P, Matters R, Erlich J, Hanna J, Asche V, Riley I. 1993. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med. J. Aust. 158:340-342.
9. Gratten M, Morey F, Dixon J, Torzillo P, Erlich J. 1995. Invasive type 12F pneumococcal disease in central Australia. Comm. Dis. Intell. 19: 470-473.
10. Proulx JF, Déry S, Jetté LP, Ismaël J, Libman M, De Wals P. 2002. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can. Commun. Dis. Rep. 28:129-131.
11. Centers for Disease Control and Prevention (CDC). 2005. Outbreak of invasive pneumococcal disease-Alaska, 2003-2004.MMWRMorb. Mortal. Wkly. Rep. 54:72-75.
12. Robinson DA, Turner JS, Facklam RR, Parkinson AJ, Breiman RF, Gratten M, Steinhoff MC, Hollingshead SK, Briles DE, Crain MJ. 1999. Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease. J. Infect. Dis. 179: 414-432.
13. Alaska Department of Labor and Workforce Development. May 2011, posting date. 2010 Census: demographic profiles. Department of Labor and Workforce Development Research and Analysis, Juneau, Alaska. http: //live.laborstats. alaska.gov/cen/dp.cfm.
14. Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, Butler JC, Schuchat A. 2004. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J. Infect. Dis. 190:2031-2038.
15. Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, Moore M, Parkinson AJ, Schuchat A, Butler JC. 2005. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 23:5464-5473.
16. Rudolph KM, Parkinson AJ, Roberts MC. 1998. Molecular analysis by pulsed-field gel electrophoresis and antibiogram of Streptococcus pneumoniae serotype 6B isolates from selected areas within the United States. J. Clin. Microbiol. 36:2703-2707.
17. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
18. Enright MC, Spratt BJ. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
19. Rakov AV, Ubukata K, Robinson DA. 2011. Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing. Infect. Genet. Evol. 11: 1929-1939.
20. Musher DM, Groover JE, Reichler MR, Riedo FX, Schwartz B, Watson DA, Baughn RE, Breiman RF. 1997. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. J. Infect. Dis. 24: 441-446.
21. Weinberger DM, Dagan R, Givon-Lavi N, Rogev-Yochay G, Malley R, Lipsitch M. 2008. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J. Infect. Dis. 97:1511-1518.
22. Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, Hendricks KA, Musher DM, Elliott JA, Facklam RR, Breiman RF. 1994. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N. Engl. J. Med. 331:643-648.
23. Cherian TC, Steinhoff MC, Harrison LH, Rohn D, McDougal LK, Dick J. 1994. A cluster of invasive pneumococcal disease in young children in child care. JAMA 271:695-697.
24. Lee EH, Hosea S, Schulman E, Bellomy A, Jackson D, Glass N, Nguyen D, Sekhar J, Kimura A, Feikin D. 2005. Streptococcus pneumoniae serotype 12F outbreak in a homeless population-California, 2004, p 79. Abstr. 54th Annu. Epidemic Intell. Serv. Conf., Atlanta, GA.
25. Tyrrell G, Lovgren M, Kellner J, Grimsrud K, Hoang L, Patrick D, Horseman G, Van Caeseele P. 2008. A large outbreak of invasive Streptococcus pneumoniae serotype 5 in western Canada, abstr S05-O2. Abstr. 6th Int. Symp. Pneumococci Pneumococcal Dis., Reykjavik, Iceland.
26. Dagan R, Gradstein S, Belmaker I, Porat N, Siton Y, Weber G, Janco J, Yagupsky P. 2000. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in Southern Israel. Clin. Infect. Dis. 30:319-321.
27. Basarab M, Ihekweazu C, George R, Pebody R. 2011. Effective management in clusters of pneumococcal disease: a systematic review. Lancet Infect. Dis. 11:119-130.
28. Ndiaye AA, De Wals P, Proulx JF, Ouakki M, Jette L, Dery S. 2006. Impact of a mass immunization campaign to control an outbreak of severe respiratory infections in Nunavik, Northern Canada. Int. J. Circumpolar Health 65:297-304.
29. Butler JC, Breiman RF, Campbell JF, Lipmann HB, Broome CV, Facklam RR. 1993. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 270:1826-1831.
30. Singleton RJ, Butler JC, Bulkow LR, Hurlburt D, O'Brien KL, Doan W, Parkinson AJ, Hennessy TW. 2007. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults. Vaccine 25:2288-2295.